Your browser doesn't support javascript.
loading
Feasibility of In Vivo Metal Artifact Reduction in Contrast-Enhanced Dedicated Spiral Breast Computed Tomography.
Wetzl, Matthias; Wenkel, Evelyn; Steiding, Chrisitan; Ruth, Veikko; Emons, Julius; Wasser, Martin N; Uder, Michael; Ohlmeyer, Sabine.
Afiliação
  • Wetzl M; Department of Radiology, University Hospital Erlangen, Maximiliansplatz 3, 91054 Erlangen, Germany.
  • Wenkel E; Department of Radiology, University Hospital Erlangen, Maximiliansplatz 3, 91054 Erlangen, Germany.
  • Steiding C; AB-CT-Advanced Breast-CT GmbH, Henkestrasse 91, 91052 Erlangen, Germany.
  • Ruth V; AB-CT-Advanced Breast-CT GmbH, Henkestrasse 91, 91052 Erlangen, Germany.
  • Emons J; Department of Gynecology and Obstetrics, University Hospital Erlangen, Universitätsstraße 21/23, 91054 Erlangen, Germany.
  • Wasser MN; Department of Radiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Uder M; Department of Radiology, University Hospital Erlangen, Maximiliansplatz 3, 91054 Erlangen, Germany.
  • Ohlmeyer S; Department of Radiology, University Hospital Erlangen, Maximiliansplatz 3, 91054 Erlangen, Germany.
Diagnostics (Basel) ; 13(19)2023 Sep 26.
Article em En | MEDLINE | ID: mdl-37835805
ABSTRACT

BACKGROUND:

Radiopaque breast markers cause artifacts in dedicated spiral breast-computed tomography (SBCT). This study investigates the extent of artifacts in different marker types and the feasibility of reducing artifacts through a metal artifact reduction (MAR) algorithm.

METHODS:

The pilot study included 18 women who underwent contrast-enhanced SBCT. In total, 20 markers of 4 different types were analyzed for artifacts. The extent of artifacts with and without MAR was measured via the consensus of two readers. Image noise was quantitatively evaluated, and the effect of MAR on the detectability of breast lesions was evaluated on a 3-point Likert scale.

RESULTS:

Breast markers caused significant artifacts that impaired image quality and the detectability of lesions. MAR decreased artifact size in all analyzed cases, even in cases with multiple markers in a single slice. The median length of in-plain artifacts significantly decreased from 31 mm (range 11-51 mm) in uncorrected to 2 mm (range 1-5 mm) in corrected images (p ≤ 0.05). Artifact size was dependent on marker size. Image noise in slices affected by artifacts was significantly lower in corrected (13.6 ± 2.2 HU) than in uncorrected images (19.2 ± 6.8 HU, p ≤ 0.05). MAR improved the detectability of lesions affected by artifacts in 5 out of 11 cases.

CONCLUSION:

MAR is feasible in SBCT and improves the image quality and detectability of lesions.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Diagnostics (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Diagnostics (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha